| Description | Tetrathiomolybdate (TM) promotes the dimerization of the metal-binding domain (WLN4) of the cellular copper efflux protein ATP7B through its characteristic sulfur bridge Mo2S6O2 cluster, and is used in the clinical treatment of Wilson’s disease. |
| molecular weight | 224.2 |
| Molecular formula | MoS4 |
| CAS | 16330-92-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Fang T, et al. Nat Commun. 2019 Jan 14;10(1):186. |